- Home
- » e-Newsletters
CDC panel recommends more teens receive bacterial meningitis vaccine
Infection Control Monitor, June 29, 2007
A panel of advisors to the CDC recommended this week that more teens be vaccinated against bacterial meningitis.
The panel recommended all 11- to 18-year-olds should receive Menactra, also known as meningococcal polysaccharide vaccine or MCV4, which the government now recommends for 11- and 12-year-olds, The Washington Post reported.
Bacterial meningitis, while relatively rare, can cause seizures, brain damage, memory loss, and even death by involving the inflammation of membranes covering the brain and spinal cord.
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched